PharmiWeb.com - Global Pharma News & Resources

Press Releases

Date Title Company
03-Apr-2025 Preclinical success for gene control system for Rett Syndrome Edinburgh Innovations
03-Apr-2025 PEPITEM sequence shows effects in psoriasis, comparable to steroid cream University of Birmingham
03-Apr-2025 Hansa Biopharma to host Q1 2025 interim results conference call Hansa Biopharma
03-Apr-2025 Akiram Therapeutics initiates Eurostars-funded collaboration to develop next-generation targeted alpha-therapeutics Akiram Therapeutics
03-Apr-2025 Elekta and Azra AI announce partnership to enhance cancer registry operations with AI-powered automation Elekta
03-Apr-2025 AlzeCure Pharma publishes its Annual Report for 2024 AlzeCure Pharma
03-Apr-2025 Cambridge Cognition selected for two Phase 3 trials combining digital cognitive and voice solutions Cambridge Cognition
03-Apr-2025 Phesi launches self-service Investigator Site Profiler solution to enhance precision of investigator site selection Phesi
03-Apr-2025 OncoZenge presents BupiZenge™ Phase 3 abstract at leading supportive cancer care conference in the US in June OncoZenge
03-Apr-2025 CSL Behring and GKV-Spitzenverband Agree on Reimbursement Price for HEMGENIX® – Europe's First Gene Therapy for Haemophilia B CSL Behring
03-Apr-2025 Novo Nordisk announces changes in Executive Management Novo Nordisk
03-Apr-2025 Stryker completes sale of U.S. spinal implants business Stryker
03-Apr-2025 Labcorp Launches First-of-its-Kind Immunoassay to Accelerate Path to Diagnosis of Alzheimer's Disease Labcorp
03-Apr-2025 Abbott Introduces Next-Generation Delivery System to Streamline Electrode Placement During Dorsal Root Ganglion Stimulator Implantations Abbott
03-Apr-2025 UniDoc Announces Debt Settlement and Renews Marketing Engagement ACCESS Newswire
03-Apr-2025 Roche provides update on Phase III OCREVUS high dose study in people with relapsing multiple sclerosis Roche
03-Apr-2025 Boehringer Ingelheim strengthens antibody-drug conjugate portfolio with new NBE Therapeutics R&D center in Basel Boehringer Ingelheim
03-Apr-2025 Aptevo Therapeutics $2.1 Million Registered Direct Offering and Concurrent Private Placement Priced At-The-Market Under Nasdaq Rules ACCESS Newswire
03-Apr-2025 Artificial Intelligence in Pharmacovigilance: Advancing Drug Safety with Real-World Data Insights Medi-Tech Insights
03-Apr-2025 March Monthly Update - Continued Growth and Important Progress ACCESS Newswire